SCHEMBL8411323

SCHEMBL8411323

CCCN1C(N2CCC(C(=O)c3ccc(F)cc3)CC2)C(OC)c2c(OC)cccc2S1(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.46
CYP2D6 P10635 1/20 0.46
HSD11B1 P28845 5/20 0.46
LMNA P02545 3/20 0.46
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 1/20 0.44
HTT P42858 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
SLC18A3 Q16572 2/20 0.41
MEN1 O00255 1/20 0.41
UBE2N P61088 1/20 0.41
BLM P54132 1/20 0.40
HTR2A P28223 1/20 0.40
GRM2 Q14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8412352 0.90 CYP2D6 (0.47) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8413001 0.84 L3MBTL1 (0.41) CYP2C19CYP2D6LMNAKMT2AALDH1A1
SCHEMBL8412311 0.82 HSD11B1 (0.47) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8413904 0.81 CYP2C19 (0.46) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8409854 0.80 CYP2C19 (0.45) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8413553 0.80 HSD11B1 (0.45) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8412314 0.79 CYP2D6 (0.44) CYP2C19CYP2D6HSD11B1LMNAKMT2A
SCHEMBL8410572 0.79 KMT2A (0.42) CYP2C19KMT2AHSD17B10TDP1ALDH1A1
SCHEMBL8413423 0.79 HTR7 (0.43) KMT2AMEN1HTR2A
SCHEMBL8410851 0.78 SLC18A3 (0.47) CYP2C19CYP2D6HSD11B1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed